Abstract
Pulmonary hypertension and severe hypoxemia complicate the care of patients with diseases such as the acute respiratory distress syndrome (ARDS). Numerous vasodilator therapies aimed at reducing pulmonary hypertension have been tested in these patients. All of the currently available intravenous vasodilators produce systemic vasodilation and hypotension at dosages sufficient to reduce the pulmonary artery pressure. In addition, intravenous infusions of systemic vasodilators such as nitroprusside or prostacyclin (prostaglandin I2; PGI2) markedly increase the venous admixture (Radermacher et al. 1990). In 1991, inhaled nitric oxide (NO) was reported to selectively vasodilate the pulmonary circulation (Fratacci et al. 1991; Frostell et al. 1991). The use of this novel therapy as an adjunct in the treatment of ARDS has attracted immense interest.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abman SH, Kinsella JP, Schaffer MS, & Wilkening RB. 1993. Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension. Pediatrics 92:606–609.
Anonymous. 1997a. Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. The Neonatal Inhaled Nitric Oxide Study Group (NINOS). Pediatrics 99:838–845.
Anonymous. 1997b. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. The Neonatal Inhaled Nitric Oxide Study Group. N Engl J Med 336:591–604.
Assreuy J, Cunha FQ, Liew FY, & Moncada S. 1993. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol 105:833–837.
Benzing A, Bräutigam P, Geiger K, Loop T, Beyer U, & Moser E. 1995. Inhaled nitric oxide reduces pulmonary transvascular albumin flux in patients with acute lung injury. Anesthesiology 83:1153–1161.
Bigatello LM, Hurford WE, Kacmarek RM, Roberts JD Jr, & Zapol WM. 1994. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Effects on pulmonary hemodynamics and oxygénation. Anesthesiology 80:161–710.
Boughton SN, Deakin AM, & Whittle BJ. 1992. Actions of nitric oxide on the acute gastrointestinal damage induced by PAF in the rat. Ann NY Acad Sci 664:126–139.
Braner DAV, Fineman JR, Chang R, & Soifer SJ. 1993. M&B 22948, a cGMP phos-phodiesterase inhibitor, is a pulmonary vasodilator in lambs. Am J Physiol 264: H252–H258.
Clancy RM, Leszynska-Piziak J, & Abramson SB. 1992. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil Superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 90:1116–1121.
Dahm P, Blomquist S, Martensson L, Thorne J, & Zoucas E. 1994. Circulatory and venti-latory effects of intermittent nitric oxide inhalation during porcine endotoxemia. J Trauma 37:169–111.
Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, Davis K, Hyers TM, Papadakos P, and the Inhaled Nitric Oxide in ARDS Study Group. 1998. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Crit Care Med 26:15–23.
DeMarco V, Skimming J, Ellis TM, & Cassin S. 1994. Nitric oxide inhalation: effects on the ovine neonatal pulmonary and systemic circulations. Chest 105:91S-92S.
Etches PC, Finer NN, Barrington KJ, Graham AJ, & Chan WK. 1994. Nitric oxide reverses acute hypoxic pulmonary hypertension in the newborn piglet. Pediatr Res 35:15–19.
Fierobe L, Brunet F, Dhainaut JF, Monchi M, Belghith M, Mira JP, Dall’ava-Santucci J, & Dinh-Xuan AT. 1995. Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome. Am J Respir Crit Care Med 151:1414–1419.
Fratacci MD, Frosteil CG, Chen TY, Wain JC Jr, Robinson DR, & Zapol WM. 1991. Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 75:990–999.
Frostell C, Fratacci MD, Wain JC, Jones R, & Zapol WM. 1991. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83:2038–2047.
Garat C, Adnot S, Reyaiguia S, Meignan M, & Jayr C. 1994. Effect of inhaled nitric oxide on 100% oxygen induced lung injury in rats. Anesthesiology 87:A1454.
Garat C, Adnot S, Rezaiguia S, Kouyoumdjian C, Meignan M, & Jayr C. 1995. Effect of inhaled NO or treatment with L-NAME on 100% oxygen induced lung injury in rats. Am J Respir Crit Care Med 157:A757.
Gerlach H, Rossaint R, Pappert D, & Falke KJ. 1993. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 23:499–502.
Guidot DM, Repine MJ, Hybertson BM, & Repine JE. 1995. Inhaled nitric oxide prevents neutrophil-mediated, oxygen radical-dependent leak in isolated rat lungs. Am J Physiol 269(1 Pt 1):L2–L5.
Harris AL, Lemp BM, Bentley RG, Perrone MH, Hamel LT, & Silver PJ. 1989. Phospho-diesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle. J Pharmacol Exp Ther 249:394–400.
Hassoun PM, Yu FS, Zulueta JJ, White AC, & Lanzillo JJ. 1995. Effect of nitric oxide and cell redox status on the regulation of endothelial cell xanthine dehydrogenase. Am J Physiol 268:L809-LS17.
Hoffman GM, Ross GA, Day SE, Rice TB, & Nelin LD. 1997. Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Crit Care Med 25:352–359.
Hogman M, Frostell C, Arnberg H, Sandhagen B, & Hedenstierna G. 1994. Prolonged bleeding time during nitric oxide inhalation in the rabbit. Acta Physiol Scand 151:125–129.
Holzmann A, Bloch KD, Sanchez LS, Filippov G, & Zapol WM. 1996. Hyporesponsive-ness to inhaled nitric oxide in isolated, perfused lungs from endotoxin-challenged rats. Am J Physiol 271:L981–L986.
Hopkins SR, Johnson EC, Richardson RS, Wagner H, De Rosa M, & Wagner PD. 1997. Effects of inhaled nitric oxide on gas exchange in lungs with shunt or poorly ventilated areas. Am J Respir Crit Care Med 156:484–491.
Houmes RJ, Hartog A, Verbrugge SJ, Bohm S, & Lachmann B. 1997. Combining partial liquid ventilation with nitric oxide to improve gas exchange in acute lung injury. Intensive Care Med 23:163–169.
Hughes SR, Williams TJ, & Brain SD. 1990. Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. Eur J Pharmacol 191: 481–484.
Hutcheson IR, Whittle BJ, & Boughton SN. 1990. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Eur J Pharmacol 191:485–488.
Ialenti A, Ianaro A, Moncada S, & Di RM. 1992. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 211:177–182.
Ichinose F, Adrie C, Hurford WE, & Zapol WM. 1995. Prolonged pulmonary vasodilator action of inhaled nitric oxide by zaprinast in awake lambs. J Appl Physiol 78: 1288–1295.
Kanner J, Harel S, & Granit R. 1991. Nitric oxide as an antioxidant. Arch Biochem Biophys 289:130–136.
Karamanoukian HL, Glick PL, Wilcox DT, Rossman JE, Holm BA, & Morin FC III, 1995. Pathophysiology of congenital diaphragmatic hernia. VIII: inhaled nitric oxide requires exogenous surfactant therapy in the lamb model of congenital diaphragmatic hernia. J Pediat Surg 30:1–4.
Kavanagh BP, Mouchawar A, Goldsmith J, & Pearl RG. 1994. Effects of inhaled NO and inhibition of endogenous NO synthesis in oxidant-induced acute lung injury. J Appl Physiol 76:1324–1329.
Kiff RJ, Moss DW, & Moncada S. 1994. Effect of nitric oxide gas on the generation of nitric oxide by isolated blood vessels: implications for inhalation therapy. Br J Pharmacol 113:496–498.
Kinsella JP, Ivy DD, & Abman SH. 1994. Inhaled nitric oxide improves gas exchange and lowers pulmonary vascular resistance in severe experimental hyaline membrane disease. Pediatr Res 36:402–408.
Kinsella JP, Shaffer E, Neish SR, & Abman SH. 1992. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:8819–8820.
Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, Redding GJ, de Lemos RA, Sardesai S, McCurnin DC, et al. 1997. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediat 131:55–62.
Klemm P, Thiemermann C, Winkmaier G, Martorana PA, & Henning R. 1995. Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock. Br J Pharmacol 224:363–368.
Kouyoumdjian C, Adnot S, Levame M, Eddahibi S, Bousbaa H, & Raffestin B. 1994. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J Clin Invest 94:578–584.
Krafft P, Fridrich P, Fitzgerald RD, Koc D, & Steltzer H. 1996. Effectiveness of nitric oxide inhalation in septic ARDS. Chest 109:486–493.
Kubes P. 1992. Nitric oxide modulates epithelial permeability in the feline small intestine. J Physiol 262 it(Gastrointestin 25):G113–G1142.
Kubes P, Kanwar S, Niu X-F, & Gaboury JP, 1993. Nitric oxide synthesis inhibition induces leukocyte adhesion via Superoxide and mast cells. FASEB J 7:1293–1299.
Lundin S, Mang H, Smithies M, et al. 1997. Inhalation of nitric oxide in acute lung injury: preliminary results of a European multicenter study. Intensive Care Med 23 (suppl 1):S2.
Manktelow C, Bigatello LM, Hess D, & Hurford WE. 1997. Physiological determinants of the response to inhaled nitric oxide in patients with the acute respiratory distress syndrome. Anesthesiology 87:291–301.
May GR, Crook P, Moore PK, & Page CP. 1991. The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit. Br J Pharmacol 102:159–163.
Mayhan WG. 1992. Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5’-diphosphate and bradykinin. Inflammation 16:295–305.
McMahon TJ, Ignarro LJ, & Kadowitz PJ. 1993. Influence of zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed. J Appl Physiol 74:1704–1711.
Miller OL, Tang SF, Keech A, & Celermajer DS. 1995. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet 346:51–52.
Mulligan MS, Hevel JM, Marietta MA, & Ward PA. 1991. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sei USA 88:6338–6342.
Nelin LD, Moshin J, Thomas CJ, Sasidharan P, & Dawson CA. 1994. The effect of inhaled nitric oxide on the pulmonary circulation of the neonatal pig. Pediatr Res 35:20–24.
Nelin L, Dolinski S, Morrisey J, & Dawson C. 1995. The effect of inhaled nitric oxide on survival of rats in oxygen. Am J Respir Crit Care Med 151: A757.
Nozik ES, Huang Y-CT, & Piantadosi CA. 1995. L-Arginine enhances injury in the isolated rabbit lung during hyperoxia. Respir Physiol 100:63–14.
Ogura H, Cioffi WG Jr, Jordan BS, Okerberg CV, Johnson AA, Mason AD Jr, & Pruitt BA Jr. 1994a. The effect of inhaled nitric oxide on smoke inhalation injury in an ovine model. J Trauma 37:294–302.
Ogura H, Cioffi WG, Offner PJ, Jordan BS, Johnson AA, & Pruitt BA Jr. 1994b. Effect of inhaled nitric oxide on pulmonary function after sepsis in a swine model. Surgery 116:313–321.
Payen DM, Gatecel C, & Plaisance P. 1993. Almitrine effect on nitric oxide inhalation in adult respiratory distress syndrome. Lancet 341:1164.
Peliowski A, Finer NN, Etches PC, Tierney AJ, & Ryan CA. 1995. Inhaled nitric oxide for premature infants after prolonged rupture of the membranes. J Pediat 126:450–453.
Pison U, Lopez FA, Heidelmeyer CF, Roissant R, & Falke KJ. 1993. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J Appl Physiol 74:1287–1292.
Putensen C, Rasanen J, & Downs JB. 1994a. Effect of endogenous and inhaled nitric oxide on the ventilation-perfusion relationships in oleic-acid lung injury. Am J Respir Crit Care Med 150:330–336.
Putensen C, Rasanen J, Lopez FA, & Downs JB. 1994b. Continuous positive airway pressure modulates effect of inhaled nitric oxide on the ventilation-perfusion distributions in canine lung injury. Chest 106:1563–1569.
Puybasset L, Rouby JJ, Mourgeon E, Stewart TE, Cluzel P, Arthaud M, Poete P, Bodin L, Korinek AM, & Viars P. 1994. Inhaled nitric oxide in acute respiratory failure: dose-response curves. Intensive Care Med 20:319–327.
Puybasset L, Rouby JJ, Mourgeon E, Cluzel P, Souhil Z, Law-Koune JD, Stewart T, Devilliers C, Lu Q, Roche S, et al. 1995. Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure. Am J Respir Crit Care Med 152:318–328.
Radermacher P, Santak B, Wust HJ, Tarnow J, & Falke KJ. 1990. Prostacyclin for the treatment of pulmonary hypertension in the Adult Respiratory Distress Syndrome: effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anesthesiology 72:238–244.
Rengasamy A, & Johns RA. 1993. Regulation of nitric oxide synthase by nitric oxide. Mol Pharmacol 44:124–128.
Rimar S, & Gillis CN. 1993. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 88:2884–2887.
Roberts JD Jr, Polaner DM, Lang P, & Zapol WM. 1992. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:818–819.
Roberts JD Jr, Chen TY, Kawai N, Wain J, Dupuy P, Shimouchi A, Bloch K, Polaner D, & Zapol WM. 1993. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ Res 72:246–254.
Roberts JD Jr, Roberts CT, Jones RC, & Zapol WM. 1995. Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. Circ Res 76:215–222.
Roberts JD Jr, Fineman JR, Morin FC III, Shaul PW, Rimar S, Schreiber MD, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, & Zapol WM, for the Inhaled Nitric Oxide Study Group. 1997. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 336:605–610.
Romand JA, Pinsky MR, Firestone L, Zar HA, & Lancaster JR Jr. 1994. Effect of inhaled nitric oxide on pulmonary hemodynamics after acute lung injury in dogs. J Appl Phys-iol 76:1356–1362.
Rosenberg AA, Kinsella JP, & Abman SH. 1995. Cerebral hemodynamics and distribution of left ventricular output during inhalation of nitric oxide. Crit Care Med 23: 1391–1397.
Rosenberg AA, Kennaugh JM, Moreland SG, Fashaw LM, Hale KA, Torielli FM, Abman SH, & Kinsella JP. 1997. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. J Pediat 131:10–15.
Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, & Zapol WM. 1993. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328:399–405.
Rossaint R, Slama K, Steudel W, Gerlach H, Pappert D, Veit S, & Falke K. 1995. Effects of inhaled nitric oxide on right ventricular function in severe acute respiratory distress syndrome. Intensive Care Med 27:197–203.
Rovira I, Chen TY, Winkler M, Kawai N, Bloch KD, & Zapol WM, 1994. Effects of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS. J Appl Physiol 76:345–355.
Samama CM, Diaby M, Fellahi JL, Mdhafar A, Eyraud D, Arock M, Guillosson JJ, Coriat P, & Rouby JJ. 1995. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 55:56–65.
Shah NS, Nakayama DK, Jacob TD, Nishio I, Imai T, Billiar TR, Exler R, Yousem SA, Motoyama EK, & Peitzman AB. 1994. Efficacy of inhaled nitric oxide in a porcine model of adult respiratory distress syndrome. Arch Surg 129:158–164.
Skimming JW, de Marco VG, & Cassin S. 1994. The effects of nitric oxide inhalation on the pulmonary circulation of preterm lambs. Pediatr Res 37:35–40.
Skimming JW, Bender KA, Hutchison AA, & Drummond WH. 1997. Nitric oxide inhalation in infants with respiratory distress syndrome. J Pediat 130:225–230.
Weitzberg E, Rudehill A, & Lundberg JM. 1993. Nitric oxide inhalation attenuates pulmonary hypertension and improves gas exchange in endotoxin shock. Eur J Pharmacol 233:85–94.
Wink DA, Hanbauer I, Krishna MC, DeGraff W, Gamson J, & Mitchell JB, 1993. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci USA 90:9813–9817.
Wysocki M, Delclaux C, Roupie E, Langeron O, Liu N, Herman B, Lemaire F, & Brochard L. 1994. Additive effect on gas exchange of inhaled nitric oxide and intravenous almitrine bismesylate in the adult respiratory distress syndrome. Intensive Care Med 20:254–259.
Young JD, Brampton WJ, Knighton JD, & Finfer SR. 1994. Inhaled nitric oxide in acute respiratory failure in adults. Br J Anaesth 73:499–502.
Zapol WM, Jones R. 1987. Vascular components of ARDS: clinical pulmonary hemodynamics and morphology. Am Rev Respir Dis 136:411–414.
Zapol WM, & Snider MT. 1977. Pulmonary hypertension in severe acute respiratory failure. N Engl J Med 296:416–480.
Zapol WM, Rimar S, Gillis N, Marietta M, & Bosken CH. 1994. Nitric oxide and the lung. NHLBI workshop summary. Am J Respir Crit Care Med 149:1375–1380.
Zayek M, Cleveland D, & Morin FC III. 1993a. Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide. J Pediatrics 122:743–750.
Zayek M, Wild L, Roberts JD, & Morin FC III. 1993b: Effect of nitric oxide on the survival rate and incidence of lung injury in newborn lambs with persistent pulmonary hypertension. J Pediat 123:947–952.
Ziegler JW, Ivy DD, Kinsella JP, Clark WR, & Abman SH. 1994. Dypyridamole, a cGMP phosphodiesterase inhibitor, augments inhaled nitric oxide induced pulmonary vasodi-lation in the ovine transitional circulation. Pediatr Res 90A:521.
Zobel G, Urlesberger B, Dacar D, Rodl S, Reiterer F, & Friehs I. 1997. Partial liquid ventilation combined with inhaled nitric oxide in acute respiratory failure with pulmonary hypertension in piglets. Pediatr Res 41:112–111.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hurford, W.E., Steudel, W., Zapol, W.M. (2000). Inhaled Nitric Oxide Therapy for Acute Respiratory Failure. In: Kadowitz, P.J., McNamara, D.B. (eds) Nitric Oxide and the Regulation of the Peripheral Circulation. Nitric Oxide in Biology and Medicine, vol 1. Birkhäuser, Boston, MA. https://doi.org/10.1007/978-1-4612-1326-0_10
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1326-0_10
Publisher Name: Birkhäuser, Boston, MA
Print ISBN: 978-1-4612-7095-9
Online ISBN: 978-1-4612-1326-0
eBook Packages: Springer Book Archive